Please login to the form below

Not currently logged in
Email:
Password:

Hay fever sufferers risking health

Hay sufferers across the country are risking their health by taking the wrong medicines for their conditions and not seeking professional medical advice
Hay sufferers across the country are risking their health by taking the wrong medicines for their conditions and not seeking professional medical advice.

According to a new survey by the Royal Pharmaceutical Society of Great Britain (RPSGB), over five million hay fever sufferers could be taking inappropriate medicines. It also showed that 73 per cent of people who experience symptoms similar to that of hay fever do not visit a healthcare provider to receive advice.

David Pruce, RPSGB director of practice and quality improvement, said that the number of people that do not seek advice about their symptoms was 'surprising'.

Pruce said: "The survey results clearly demonstrate the impacts a condition like hay fever can have on peoples' lives, with millions suffering unnecessarily. Pharmacists are highly trained health professionals and experts in medicines ñ they can play a significant role in the management of allergies including hay fever."

Allergic rhinitis, more commonly known as hay fever, becomes prevalent during the summer period affects close to 13 million people across the country. The study, which was commissioned by the RPSGB, revealed that 29 per cent of people find it difficult to concentrate and 14 per cent said hay fever symptoms impaired their ability to read. These findings could have direct implications for school, college and university students who sit exams during the summer months.

14th April 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics